Article: What Single Cell RNA Sequencing Has Taught Us about Chronic Obstructive Pulmonary Disease.
Tuberculosis and respiratory diseases
2024
Abstract: Chronic obstructive pulmonary disease (COPD) affects close to 400 million people worldwide and is the 3rd leading cause of mortality. It is a heterogeneous disorder with multiple endo-phenotypes, each driven by specific molecular networks and processes. ... ...
Abstract | Chronic obstructive pulmonary disease (COPD) affects close to 400 million people worldwide and is the 3rd leading cause of mortality. It is a heterogeneous disorder with multiple endo-phenotypes, each driven by specific molecular networks and processes. Therapeutic discovery in COPD has lagged behind other disease areas owing to a lack of understanding of its pathobiology and scarcity of biomarkers to guide therapies. Single cell RNA sequencing (scRNA-seq) is a powerful new tool to identify important cellular and molecular networks that play a crucial role in disease pathogenesis. This paper provides an overview of the scRNA-seq technology and its application in COPD and the lessons learned to date from scRNA-seq experiments in COPD. |
---|---|
Language | English |
Publishing date | 2024-02-19 |
Publishing country | Korea (South) |
Document type | Journal Article ; Review |
ZDB-ID | 2161256-0 |
ISSN | 1738-3536 ; 0378-0066 |
ISSN | 1738-3536 ; 0378-0066 |
DOI | 10.4046/trd.2024.0001 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 5937: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.